

Aperiomics, Inc.
Aperiomics' mission is to advance healthcare and revolutionize infection testing to improve human health.
- Stage $500K in TTM Revenue
- Industry Biotechnology
- Location Sterling, VA, USA
- Currency USD
- Founded October 2013
- Employees 11
- Incorporation Type C-corp
- Website aperiomics.com
Company Summary
Aperiomics' mission is to advance healthcare through better infection testing. We are the only company identifying every known bacteria, virus, parasite, & fungus. This technology addresses a huge unmet need given that 75%+ of infections are not properly identified and thus are not properly treated.
Today Show: https://www.today.com/video/inside-the-biotech-company-hoping-to-solve-medical-mysteries-58704453699
Team
-
Co-founder of Aperiomics
Serial entrepreneur
Molecular biology and Infectious disease training
Kauffman Foundation Outstanding Postdoctoral Entrepreneur 2012 -
President
Co-founder of Aperiomics
Director of Computational Biology Institute at George Washington University
Fulbright Scholar at Oxford University
Edward O. Wilson Naturalist Award
Elected as Fellow in American Association for the Advancement of Science
MA (Statistics) and PhD (Biology & Biomedical Sciences) from Washington University
Co-founded Genoma LLC, a bioinformatics consulting company, in 2002 -
Science Advirosory Board, Chair
Co- founder of Aperiomics
Assistant professor of Medicine, Biostatistics, and Bioinformatics at Boston University School of Medicine
Developed widely used analytical methods and software for analyzing high-throughput genetic, genomic, and epigenomic profiling datasets
MS degree in Statistics at Brigham Young University
MA and PhD degrees in Biostatistics from Harvard University -
Science Advisory Board
-
CTO
Alvin Chen, PhD, has more than 10 years experience in next-generation sequencing and is an expert in genomics, genetics and bioinformatics. Dr. Chen joined Aperiomics in 2015 and served as PI of the an NSF SBIR Phase II grant. He successfully developed the company’s primary platform, Xplore-PATHO℠, which uses DNA sequencing technology to identify all microbes in a single test.
-
COO
Elizabeth P. Pyle, MBA serves as Chief Operating for Aperiomics located, VA. As COO, she oversees corporate operations and quality management. Her extensive experience in business development, strategic planning, marketing, operations, and leadership will enable the company to continue on its projected growth path.
Advisors
-
Mary SylviaUnconfirmedScott MezaUnconfirmed
Previous Investors
-
National Science FoundationUnconfirmedCenter for Innovative TechnologyUnconfirmedPipeline AngelsUnconfirmed
-
VentureSouthUnconfirmedPropelXUnconfirmed
-
K Street CapitalUnconfirmed